Therapeutic Options and Cost Considerations in the Treatment of Ischemic Heart Disease

@article{Cleland1998TherapeuticOA,
  title={Therapeutic Options and Cost Considerations in the Treatment of Ischemic Heart Disease},
  author={John G. F. Cleland and Andrew A Walker},
  journal={Cardiovascular Drugs and Therapy},
  year={1998},
  volume={12},
  pages={225-232}
}
Ischemic heart disease is a serious health problem because it causes considerable mortality and morbidity. Given the limited resources for health care, it is important to establish the costs associated with the benefits of its various treatment options. We therefore assessed the costs and benefits of medical treatment versus revascularization in a hypothetical cohort of 100 patients. A spreadsheet model was constructed using published data. The main outputs of this model were health-service… CONTINUE READING